玻璃体切除联合康柏西普治疗糖尿病视网膜病变的效果

The Effects of Vitrectomy Combined With Conbercept for Diabetic Retinopathy

目的探讨玻璃体切除术联合康柏西普治疗糖尿病视网膜病变的临床疗效。方法选取2016年9月—2017年9月我院收治的50例糖尿病视网膜病变患者作为研究对象。根据随机抽签原则,将受试者分为对照组(25例)和研究组(25例)。对照组患者进行玻璃体切除术治疗,研究组患者在对照组的基础上,于玻璃体腔内注射康柏西普治疗,术后随访6个月,比较手术前后两组患者的视力情况及术后并发症发生率。结果术后随访6个月,两组患者的视力较术前均显著升高,且研究组患者在0.3以上的眼数比例高于对照组,两组比较,差异具有统计学意义(P <0.05);研究组患者术后并发症发生率低于对照组,两组比较,差异具有统计学意义(P <0.05)。结论玻璃体切除术联合康柏西普可有效改善患者视力,减少术后并发症。

Objective To explore the efects of vitrectomy combined with conbercept for diabetic retinopathy （DRP）. Methods 50 patients with diabetic retinopathy admitted to our hospital from September 2016 to September 2017 were selected as subjects. According to the principle of random drawing, the subjects were divided into control group （25 cases） and study group （25 cases）. Patients in the control group were treated with vitrectomy. Patients in the study group were treated with intravitreal injection of conbercept. The follow-up period was 6 months. The visual acuity and the incidence of postoperative complications were compared between the two groups before and after operation. Results After 6 months follow-up, the visual acuity of the two groups were signifcantly higher than that of the preoperative group, and the proportion of the eyes in the study group above 0.3 was higher than that of the control group, the diference was statistically significant （P 〈 0.05）. The incidence of postoperative complications in the study group was significantly lower than that in the control group, the difference was statistically significant （P 〈 0.05）. Conclusion The combination of vitrectomy and conbercept can improve visions with less complication.